Tirzepatide is a dual GIP/GLP-1 receptor agonist, meaning it activates two different metabolic pathways simultaneously
But even without taking weight-loss drugs, your body is still capable of producing this hormone, and what you eat may help your body make more of it
Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial
Retention of this unmodified histidine in retatrutide preserves potent glucagon receptor agonism, which is a defining structural distinction compared to tirzepatide, where this position is also histidine but the molecule lacks meaningful glucagon receptor activity due to other sequence differences
reported that the exosomes present in the CSF of PD patients exhibit -syn aggregate formation